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ABSTRACT 
 
Introduction: Hypertension and diabetes are the two most common non-communicable 
diseases seen in outpatient clinics in Sub-Saharan Africa. Promoting medication adherence is 
a major clinical hurdle to be crossed in reducing the premature morbidity and mortality 
associated with these diseases. This study explored factors that predict medication adherence 
among hypertensive and diabetic patients in Ilorin, Nigeria. 
 
Methods: This cross-sectional study was carried out among hypertensive and diabetic 
patients in outpatient clinics of a teaching hospital in Ilorin, Nigeria. Data was collected from 
1,203 patients using a validated Morisky 8-item medication adherence questionnaire. 
Multivariate ordinal logistic regression was used to model the medication adherence 
explanatory factors with SPSS version 22.  
 
Result: Less than half (43.3%) of the patients were highly adherent to their medication. The 
relative proportion for high adherence was 42.7%, 35.6% and 49.2% for hypertension, 
diabetes and both diseases respectively. The odds of medication adherence improving from 
either low to medium level or from medium to high level was explained by; age, symptoms 
count, absence of disease complication and absence of drug side effect among the patients. 
Blood pressure, gender and disease duration did not explain medication adherence among 
hypertensive and diabetic patients.  
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Conclusion: It is concluded that the discomfort experienced due to the disease condition and 
the medication regimen are important explanatory factors for patient’s medication adherence 
in the study setting. This study recommends strategies to reduce multiple drug combinations 
and promote medication adherence counselling and education among patients.  
 
Keywords: Hypertension, Diabetes, Medication adherence, Explanatory factors  
 
 
 
1.0 Introduction 
 
Hypertension and diabetes are the two most common chronic medical conditions seen in 
outpatient clinics in Sub-Saharan Africa (Bromfield S, 2013). They are both important risk 
factors for cardiovascular disease and are also leading causes of morbidity and mortality. The 
prevalence of hypertension could range from 2% to 47% among adult Nigerians (Akinlua, 
Meakin, Umar, & Freemantle, 2015) while diabetes according to various studies ranged from 
1% to 7% (Dahiru, Jibo, Hassan, & Mande, 2008; Nyenwe, Odia, Ihekwaba, Ojule, & 
Babatunde, 2003; Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, 1997). These scourge are 
expected to increase tremendously over the next few decades (Zimmet, Magliano, Herman, & 
Shaw, 2014). Despite availability of effective treatment for both diseases, studies have shown 
that majority of diabetics and hypertensive patients have poor blood glucose and blood 
pressure control respectively, mainly due to poor adherence to medication (WHO, 2003). 
According to the World Health Organization (WHO), medication adherence is the extent to 
which a person’s behaviour- taking medication, following a diet, or making healthy lifestyle 
changes corresponds with agreed upon recommendation from a health care provider (WHO, 
2003). 
 
Patient’s non-adherence to chronic diseases like hypertension and diabetes medication 
regimen is a global health problem. Therefore promoting medication adherence is a major 
clinical hurdle to be crossed in the treatment protocol. This is important because the two 
diseases require life-long medication and clinical management regimen. Non-adherence to 
medication compromises safety and treatment effectiveness leading to increased mortality and 
morbidity (Kirigia, Sambo, Sambo, & Barry, 2009). There is also concomitant financial loss 
to the health care system and patients as a result of high rate of hospitalisation (Kirigia et al., 
2009; WHO, 2014). Low patient adherence to antihypertensive and anti-diabetic medications 
had been observed to be the most important modifiable patient-related barrier to achieving 
blood pressure goals in hypertension and blood glucose control in diabetes (American 
Diabetic Association, 2011; Borzecki, Oliveria, & Berlowitz, 2005).] 
 
Identifying non-adherent patients in the outpatients’ settings is germane to effective control 
rates of hypertension and diabetes. There are 2 methods to assessing medication adherence; 
which could be direct and indirect methods. The most simple and inexpensive method to use 
in the clinical (outpatient) setting is the indirect (subjective) method, which is basically 
patient oriented self-report (Osterberg & Blaschke, 2005). A numbers of direct patient self-
reporting scales have been developed to assess adherence (Al-Qazaz et al., 2010; Korb-
Savoldelli et al., 2012). Although there is no gold standard medication adherence scale or 
questionnaire tool, however the eight item Morisky Medication Adherence Scale (MMAS-8) 
is one of the  commonly used tools that has been deemed  reliable and valid (Al-Qazaz et al., 
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2010; Korb-Savoldelli et al., 2012).[14,15]  The MMAS-8 scores  range from 0 to 8 with low 
adherence defined as MMAS scores  less than 6, medium  adherence  as scores of 6 to less 
than 8 and high adherence  as a score of 8 (Krousel-Wood, Muntner, Islam, Morisky, & 
Webber, 2009).  
 
The MMAS-8 is an improvement over an initial 4-item Morisky, Green and Levine 
Adherence Scale  which has been found insufficient to explore all the domains measured in 
medication adherence behaviour (Morisky, Green, & Levine, 1986). A new scale, the 
MMAS-4-item has been limited to the clinic settings unlike the 8-item MMAS whose usage 
has included research purposes and medical intervention assessment (Morisky DE, 2011). The 
MMAS-8 was designed to facilitate the identification of barriers and determinants of 
medication adherence in chronic illnesses (Morisky et al., 1986; Morisky DE, Ang A, 
Krousel-Wood M, 2008; Morisky DE, 2011). When compared to direct method of eliciting 
medication adherence like pharmacy fill rate, it was found to have high concordance rates 
with pharmacy fill records (Krousel-Wood et al., 2009). The MMAS has been widely 
validated in many countries and found to be internally consistent (Boima et al., 2015; Fadare, 
Olamoyegun, & Gbadegesin, 2015; Korb-Savoldelli et al., 2012). Although, some studies 
have explored factors associated with medication adherence among hypertension and diabetes 
in Nigeria (Ajayi EA, Adeoti AO, Ajayi IA, Ajayi AO, 2013; Boima et al., 2015; Fadare et 
al., 2015; Odusola et al., 2014), none was sighted to report on the factor(s) that predict 
adherence among  patients with hypertension and diabetes, either separately or together in the 
study area. This study was therefore carried out to explore the factors that determine and 
explain (predict) medication adherence among hypertensive and diabetic patients in Ilorin, 
Nigeria.  
 
 
 
2.0 Materials and Methods 
 
2.1 Study Setting 
 
This study was conducted at the University of Ilorin Teaching Hospital (UITH) located in 
Ilorin, a city in north-central Nigeria. It is a tertiary hospital and receives referral from public 
and private primary and secondary hospitals within and outside the state. The catchment area 
of UITH covers more than 5 states of Nigeria including Kwara State where it is located. The 
hospital has many clinics that render outpatients care to patients but majority of hypertensive 
and diabetic patients are attended to at the General Outpatient Department (GOPD) and 
Medical Outpatient Department (MOPD). On a daily average, close to 90 patients with 
hypertension and diabetes were attended to in both clinics in 2014. There was 4:1 female to 
male attendance ratio in the 2 clinics in the same year.  Only patients attending the GOPD and 
the MOPD clinics were included into this study. 
 
2.2 Study Design 
 
The study is a cross-sectional study with comparative analysis of registered patients with 
hypertension and diabetes who were attending outpatient clinics of UITH Ilorin. The study 
was carried out on clinic days with the exclusion of public holidays. Patients were recruited 
proportionate to sizes of hypertension and diabetic ratio (ratio 9:1 from hospital attendance 
records). Consecutive patients were included in the study until the desired sample size of 
International Journal of Public Health and Clinical Sciences 
e-ISSN : 2289-7577. Vol. 4:No. 4 
July/August 2017  
 
Bolarinwa O.A, et al. 129 
 
 IJPHCS  
Open Access: e-Journal 
  
 
 
1,203 was attained. Patients were included into the study after an informed consent was 
obtained. The consenting adult patients (of over 18 years of age) were included in this study. 
 
2.3 Informed Consent and Ethics 
 
This study was conducted based on good clinical practice for biomedical researches according 
to the Collaborative Institutional Training Initiative (CITI) guidelines. All eligible patients 
had research background information given to them in the language they best understood 
before seeking their consent for the study. Valid consent was obtained from all the 
participating patients in written form by either signature or thumb printing. Ethical approval 
for this study was obtained from the UITH Ethical Review Committee approval no 
ERC/PAN/2014/07/1332.  
 
2.4 Data Collection 
 
A Clinical Report Form (CRF) and questionnaire were used for collecting data for this study. 
Data was collected between October 2014 and April 2015. The CRF collected data on 
patients’ medical information and conditions which were; Blood Pressure (BP), Body Mass 
Index (BMI), disease history, drug history, complication and co-morbidity history and 
hospital follow-up history. The Questionnaire was sectioned into 4 parts namely; socio-
demography, clinical/drug profile, clinical measurements and medication adherence.  
 
Adherence to treatment by the patients was assessed using the 8-item Morisky Medication 
Adherence Scale (MMAS 8-scale) (Morisky DE, Ang A, Krousel-Wood M, 2008). This tool 
contains dichotomous measure and one Lickert measure.  All the 8 items in MMAS-8 
questionnaire added up to a maximum score of 8.  The eight-item compliance scale had an 
alpha reliability of 0.83 (n= 1367) among patients diagnosed with essential hypertension 
attending an outpatient clinic of a large teaching hospital (Morisky DE, Ang A, Krousel-
Wood M, 2008). Permission to use of the MMAS scales is required.  Reproduction and 
distribution of the MMAS is protected by US copyright laws. License for the use of MMAS 
was obtained from the Copyright owner. 
 
2.5 Statistical Analysis 
 
Data was analysed using IBM© SPSS version 22. The frequency distribution of socio-
demographic, clinical information and drug information were analysed with descriptive 
statistics.  The MMAS-8 was scored and with a range from 0 to 8. The low adherence was 
defined as MMAS scores less than 6, while medium adherence as scores of 6 to less than 8. 
The high adherence was a score of 8. Prevalence of medication adherence (low, medium and 
high) was then analysed. The inferential statistics provided information on how socio-
demographic factors, clinical conditions and drug history determined medication adherence. 
Chi-square test and F-test were used to elicit these associations. Explanatory analysis was 
performed to study how initially significantly associated factors predicted medication 
adherence. Age, gender, blood pressure, drug side effect, symptom counts, co-morbidity and 
disease duration were all the risk factors subjected to the modeling. Both univariate and 
multivariate Ordinal Logistic Regressions (OLR) models were used to explore the 3 (low 
⁄medium⁄ high) ordinal levels of medication adherence. The OLR model compared adjacent 
levels which means the odds ratio (OR) corresponded with the odds of medication adherence 
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in the next higher level. Odd ratios are presented with their 95% confidence interval (95% CI) 
while statistical significance was set at p-value of < 0.05. 
 
 
 
3.0 Result 
 
3.1 Patient Characteristics 
 
The socio-demographic characteristics of the patients studied are presented in Table 1below, 
 
Table 1: Socio-demographic Characteristics (n=1203) 
VARIABLES                                   FREQ (%)  Mean (SD) 
Age    
21-30 18 (1.5) 57.5   (12.3) 
31-40 94 (7.8)  
41-50 243 (20.2)  
51-60 385 (32.0)  
61-70 315 (26.2)  
>70 148 (12.3)  
 
Gender 
  
 
Male 319 (26.5)  
Female 884 (73.5)  
 
Ethnicity 
  
 
Yoruba 1111 (92.3)  
Hausa 6 (0.5)  
Igbo 18 (1.5)  
Others 68 (5.7)  
 
Educational level 
  
 
No formal education 449 (37.3)  
Primary 265  (22.1)  
Secondary 194 (16.1)  
Tertiary 295 (24.5)  
    
Marital status     
Married 899 (74.7)  
Single 17 (1.4)  
Divorced 24 (2.0)  
Widowed 263 (21.9)  
    
Main job
    
No paid job 1116  (92.8)  
Paid job 87 (7.2)  
    
Poverty level
    
< 2 dollars 538  (45.4)  
> 2 dollars 648  (54.6)  
 
The mean age of the patients was 57 years +12 years with female predominance (73.5%). 
Over 90% were Yoruba tribe and sizeable proportion (36.9%) of the patients did not have 
formal education. Though about three-quarters of participants (74.7%) were married, more 
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than a fifth has lost their spouses. Only 7.2% of the respondents were on paid job and about 
45% of the patients lived on less than 2 USD per day.  
 
3.2 Clinical Data and Medication Use Pattern 
 
Clinical data and medication use pattern of patients presented as Table 2 below, 
 
Table 2: Patients’ Clinical Factors (n= 1203) 
VARIABLES                                                                    FREQ (%) Median (IQR) 
 
Methods of payment (n=1203) 
  
 
 Out of Pocket 611 (50.8)  
Health Insurance 111 (9.2)  
 Employer 26 (2.2)  
Relative 455 (37.8)  
 
Morbidity profile (n = 1203) 
  
 
HYPERTENSION 965 (80.2)  
Diabetes 59 (4.9)  
Both 179 (14.9)  
 
Disease Duration (n = 1188) 
   
<1year 194 (16.3) 5.2  (8.3) 
1-5year 388 (32.7)  
5-10year 254 (21.4)  
>10years 352 (29.6)  
    
Disease complication (n= 1198)
    
Yes  378  (31.6)  
No 820 (68.4)  
 
Follow-up visits affect daily activity (n = 1200) 
  
 
Yes 386 (32.2)  
No 814 (67.8)  
 
Drug combination (n = 1200) 
  
 
One 98 (8.2)  
Two 398 (33.1)  
three 410 (34.2)  
>three 294 (24.5)  
 
Drug frequency  (n = 1200) 
  
 
Once 875 (72.9)  
Twice 300 (25.0)  
Thrice 24 (2.0)  
> Thrice 1 (0.1)  
 
Drug side effect  (n = 1200) 
  
 
Yes 179 (14.9)  
No 1021 (85.1)  
    
Symptom count (n=1203)    
No symptom 1046 (86.9)  
1 symptom 97   (8.1)  
2 symptoms 40   (3.3)  
> 3 symptoms 20   (1.7)  
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Table 2 shows that about half of the patients paid out of pocket for their medical bill. Four out 
of every five patients studied have hypertension without diabetes mellitus while only 4.9% 
have only diabetes mellitus without hypertension. Close to 15% of e patients have both 
hypertension and diabetes mellitus. More than three-quarter of the patients have had the 
disease for more than a year and almost a third (29.6%) of them had lived with the disease for 
more than 10 years. About 15% of them have lived with the complications of these diseases 
like stroke and congestive heart failure. Follow-up visit affects daily activities in 32.2% of the 
patients. Over half of the patients take 3 or more drugs for their medical conditions while 
close to three-quarter (72.9%) of the patients take a daily dose of drug. Close to 15% of the 
patients experienced drug side effect. The mean symptom count for the patients is 0.19 + 
0.56. 
 
3.3 Medication Adherence Pattern   
 
Less than half (43.3%) of the patients were highly adherent to their medication. Respondents 
with medium and low adherence were 30.3% and 26.7% respectively (Tables 3&4). The 
relative proportions of adherence pattern among the 3 types of disease profile studied are 
shown in Figure 1.  
 
 
          Figure 1: Medication Adherence Pattern among Patients 
 
Patients with hypertension had 42.7%, 30.7% and 26.6% for high, medium and low 
medication adherence respectively while those with diabetes had 35.6%, 35.6% and 28.8% for 
high, medium and low adherence, respectively. The patients with the comorbidity of 
hypertension and diabetes had 49.2%, 26.3% and 24.6% for high, medium and low 
adherences respectively (Figure 1). 
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3.4 Factors Associated with Medication Adherence 
 
Age (p<0.001), educational status (p=0.018) and poverty level (p=0.005) were significantly 
associated with medication adherence (Table 3). Specifically, on post hoc analysis there was 
significant difference between ages of those with high (p=0.009) and medium (p=0.005) 
adherence compared to those with low adherence. Those patients of high and medium 
adherence have higher mean age (58.17 and 56.21 years respectively) compared with those of 
low adherence (55.41 years). 
 
Table 3: Socio-demographic Factors Associated with Medication Adherence  
Variables Low adherence 
(0 - <6) 
N=318 (26.4)  
Medium Adherence 
(6 - <8) 
N= 364 (30.3)  
High Adherence 
(8) 
N=521 (43.3)  
Age*
a^    
Mean (S.D) 55.41(11.4) 56.21(12.9) 58.17 (12.2) 
    
Gender
b    
Male 77  (24.2) 107 (33.5) 135 (42.3) 
Female 241 (27.3) 257 (29.0) 386 (43.7) 
    
Ethnicity
b    
Yoruba 291 (26.2)  331 (29.8) 489 (44.0) 
Others   27 (29.3)   33 (35.9)   32 (34.8) 
    
Educational Level*
b    
No formal education 96 (21.4) 132 (29.4) 221 (49.2) 
Primary 76 (28.7)  82 (30.9)  107 (40.4) 
Secondary 65 (33.5)  55 (28.4)  74 (38.1) 
Tertiary 81 (27.5)  95 (32.2) 119 (40.3) 
    
Main Job
b    
No paid job 300 (26.9) 340 (30.5) 476 (42.6) 
Paid job  18 (20.7)  24 (27.6)   45 (51.7) 
    
Poverty level*
b    
< 2 dollars 132 (24.5) 145 (27.0) 261 (48.5) 
> 2 dollars 183 (28.2) 211 (32.6) 254 (39.2) 
a = F-test, b= chi-square test * = significant (p-value < 0.05),  
^ = Equal variance assumed, #  = Equal variance un-assumed 
 
 
The clinical and drug related variables that were significantly associated with medication 
adherence were (Table 4); mode of payment for medical bill (p=0.03), disease complication 
(p<0.001), drug combination (p=0.001), drug side effect (p<0.001) and symptom counts 
(p<0.001). Those patients with high medication adherence had higher symptom counts than 
those with medium (p<0.001). The BP control was not found to be significantly associated 
with medication adherence (p>0.05) 
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Table 4: Clinical Factors Associated with Medication Adherence  
Variables Low adherence 
(0 - <6) 
N=318 (26.4)  
Medium Adherence 
(6 - <8) 
N= 364 (30.3)  
High Adherence 
(8) 
N=521 (43.3)  
Methods of payment for 
Follow-up care*
b 
   
Out of pocket 173 (28.3) 168 (27.5) 370 (44.2) 
Health Insurance  40 (36.0)  39 (35.1)   32 (28.9) 
Employer  03 (11.5)  11 (42.3)  12 (46.2) 
Relative 102 (22.4) 146 (32.1) 207 (45.5) 
    
Morbidity profile
b    
Hypertension 257 (26.6) 296 (30.7) 412 (42.7) 
Diabetes  17 (28.8)  21 (35.6)  21 (35.6) 
Both  44 (24.6) 47 (26.2)  88 (49.2) 
    
Disease duration
a    
Mean  (S.D) 7.8 (6.9) 6.9 (5.9) 7.4 (6.2) 
    
Complication*
b    
Yes  120 (31.7) 130 (34.4) 128 (33.9) 
No 196 (23.9) 232 (28.3) 392 (47.8) 
    
Drug Combination*
b    
One   29 (29.6)   32 (32.7)   37 (37.7) 
Two 127 (31.9) 113 (28.4) 158 (39.7) 
>Three 162 (22.9) 219 (31.0) 326 (46.1) 
    
Drug side effect*
b    
Yes  81 (45.3)  44 (24.6)  54 (30.1) 
No 234 (23.1) 320 (31.3) 467 (45.6) 
    
Symptoms count*
a#    
Mean (S.D) 0.15 (0.51) 0.14 (0.50) 0.35 (0.72) 
    
BP control
b    
Controlled 248 (25.9) 292 (30.5) 416 (43.6) 
Uncontrolled 70 (28.3) 72 (29.1) 105 (42.5) 
a = F-test, b= chi-square test * = significant (p-value < 0.05),. 
^ = Equal variance assumed,  #  = Equal variance un-assumed 
 
 
3.5 Explanatory Factors of Medication Adherence 
 
The principle underlining the OLR that was used for the explanatory analysis in this study 
inferred that the odds of medication adherence will improve from either low to medium level 
or from medium to high level of adherence.  
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Table 5: Predictors of Medication Adherence (OLR) 
 Variables Non-adjusted OR 
(95% CI)
a 
p-value
b 
Adjusted OR 
(95% CI)
a 
p-value
 
Age 1.12 (1.00, 1,23)
b 
0.006* 1.12 (1.00, 1.02)
c 
0.013* 
Drug side effect 1.28 (1.00, 1.63)
b 
0.05* 1.26 (0.99, 1.62)
c 
0.063 
No Complication 1.65 (1.32, 2.06)
b 
0.000* 1.57 (1,24, 1.99)
c 
0.000* 
Symptom counts 0.65 (0,54, 0.78)
b 
0.000* 0.69 (0.57, 0.84)
c 
0.000* 
Uncontrolled BP -0.087 (-0.30, 0.12)
b 
0.419   
Gender (Male) 0.97, (0.77, 1.23)
b 
0.827   
Disease duration 0.99, (0.98, 1.01)
b 
0.637   
OR = Odd Ration, CI = Confidence Interval. 
a
 = the odds of having medication adherence in the next level 
b 
= from univariate ordinal logistic regression  
c 
= from multivariate ordinal logistic regression  
* = statistically significant 
 
In univariate OLR analysis, Age (OR=1.12, 95%CI=1.00, 1,23), patients without disease 
complication (OR=1.65, 95%CI=1.32, 2.06), drug side effect (OR =1.28, 95%CI =1.00, 1.63) 
and symptoms counts (OR=0.65, 95%CI=0,54, 0.78) significantly explained medication 
adherence. This result means that medication adherence among the patients in this study 
increased by: i) 1.12 fold with one year increase in patients’ age, ii) Reduced by 0.69 fold 
with one unit increase in symptom counts, iii) increased by 1.28 fold if patients had drug side 
effect and  iv) by 1.65 fold with patients without disease complication. Blood Pressure (BP), 
gender and disease duration did not predict medication adherence in this study. On 
multivariate ordinal regression modelling, age (Adjusted OR=1.12), absence of complication 
(Adjusted OR=1.57) and symptom counts (Adjusted OR=0.69) fit in to model significantly to 
explain medication adherence. Though patients with uncontrolled BP had reduced odd of 
0.087 to attain medication adherence (Table 5), this was not found to be statistically 
significant (CI= -0.30, 0.12), 
 
 
 
4.0 Discussion 
 
This study reports medication adherence pattern and explanatory factors (predictors) among 
patients with hypertension and diabetes mellitus attending outpatient clinics in a north-central 
state of Nigeria. The mean age of the patients studied was 57 year which is close to retirement 
age of 60 years in civil service  in Nigeria (Ugwu, S. C., & Eme, 2011). This could possibly 
explains why majority of patients studied were not on any paid job and while close to half of 
them lived on less than 2 USD per day. This fact is reinforced by low literacy level observed 
among the study group. Despite the low earning capacity of these patients, more than half of 
them paid out of pocket for their hospital care; which is possibly due to lack of social security 
for Nigerian retirees (Ugwu, S. C., & Eme, 2011). However, the chronicity and life-long 
nature of the 2 diseases requires financial access to care. Close to 80% of patients studied 
have hypertension without diabetes, less than 5% have diabetes without hypertension, while 
close to 15% have both hypertension and diabetes mellitus. The two diseases are the most 
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common non-communicable chronic conditions seen in outpatient clinics in sub-Saharan 
Africa (Bromfield S, 2013). The observed proportion in this study conforms with other 
studies that have reported higher prevalence of hypertension compared to diabetes (Nyenwe et 
al., 2003; Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, 1997). Our finding is in agreement 
to previous finding which documented that people living with diabetes mellitus are at higher 
risk of hypertension (Long AN & Dagogo-Jack S., 2011). The comorbidity of hypertension 
and diabetes increases risk of both macrovascular and microvascular complications in the 
patients (Long AN & Dagogo-Jack S., 2011). 
 
Medication adherence pattern revealed that less than half of the patients were adherent to 
medication across the 3 disease profiles. The patients with both co-morbidity of hypertension 
and diabetes had fairly average medication adherence level. However, less than average of 
hypertensive patients and diabetic patients were adherent to their medication; a finding 
comparable to findings from that of USA (Morisky DE, Ang A, Krousel-Wood M, 2008), and 
Nigeria (Adisa, R., Fakeye, T. O., & Fasanmade, 2011; Odusola et al., 2014). These studies 
were carried out among patients attending Outpatients clinics using the MMAS. Similarly, our 
finding was comparable with majority of the centers studied in a multi-center adherence study 
carried out in Nigeria and Ghana (Boima et al., 2015). It is noteworthy to state that results of 
adherence studies that used the MMAS-8 scale have reported varying results among different 
populations (Al-Qazaz et al., 2010; Korb-Savoldelli et al., 2012; Krousel-Wood, M., Islam, 
T., Webber, L. S., Re, R., Morisky, D. E., & Muntner, n.d.; Morisky DE, Ang A, Krousel-
Wood M, 2008).  
 
Medication adherence amongst diabetic patients in our study is similar to the earlier studies 
from Nigeria (Fadare et al., 2015) and Malaysia (Al-Qazaz et al., 2010). Among Nigeria 
studies Fadare et al (2016) which used MMAS-8, and Adisa et al (2011) which employed 
MMAS-4 reported over 40% and 60% adherence respectively. The observed difference in our 
result and that of Adisa et al (2011) is probably due to the use of MMAS-4 tool as against 
MMAS-8 used in our study. Part of the advantages of the MMAS-8 over the MMAS-4 is its 
high reliability (Krousel-Wood, M., Islam, T., Webber, L. S., Re, R., Morisky, D. E., & 
Muntner, n.d.).  
 
We found a higher medication adherence level amongst patients with hypertension and 
diabetes as co-morbidity. This is an important scenario because; in clinical setting, it is 
common to see patients with stand-alone hypertension and diabetes. It is also common to find 
those with both diseases as comorbidity. Studies in Nigeria have shown that hypertension is 
an extremely common comorbidity amongst persons with diabetes mellitus and is said to be 
twice as prevalent in diabetics than in non-diabetic individuals (Chinenye et al., 2012). Thus, 
hypertension and diabetes are common, intertwined conditions that share a significant overlap 
in underlying risk factors and as potent risk factors for Cardiovascular diseases (Chinenye et 
al., 2012; Long AN & Dagogo-Jack S., 2011). It has been reported that patients with the 
comorbidity usually have poor clinical outcome more than those with one of the diseases 
(Chinenye et al., 2012). Both diseases increases mortality by 20 times in the affected person 
compared to age- and- sex matched healthy individual (Akintunde & Akintunde, 2015; 
Unadike, Eregie, & Ohwovoriole, 2011). Up till the time of writing this article, no evidence is 
sighted in the literature in Nigeria regarding medication adherence pattern among patients 
with hypertension and diabetes comorbidity. 
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Age, educational status and poverty level were identified as socio-demographic factors that 
influenced medication adherence among patients in our study. The clinical and disease factors 
that affected adherence pattern included; mode of payment, presence of complication, drug 
combination and drug side effect.  In the same vein, our results showed that older age was 
associated with better adherence. There have been diverse results from studies that have 
explored factors associated with medication adherence using MMAS-8. Older age group, 
higher educational status , lower number of medications per day and higher monthly incomes 
have been documented to facilitate adherence (Boima et al., 2015; Odusola et al., 2014). 
Factors reported to have negatively impacted on adherence to medication included; poor 
knowledge of hypertension, depression, concerns about medications, and use of herbal 
preparation (Odusola et al., 2014). One consistent finding from the majority of the earlier 
works is that older age group have a higher adherence compared to the younger age group 
(Boima et al., 2015; Krousel-Wood, M., Islam, T., Webber, L. S., Re, R., Morisky, D. E., & 
Muntner, n.d.). These has been adduced to the older people probably having more regard for 
their health, more prone to complications and hence feel more inclined to use medications. 
Previous studies have also documented significant relationships between blood pressure, 
blood glucose control and adherence to medication (Al-Qazaz et al., 2010; Krousel-Wood et 
al., 2009). However, these factors were not significantly associated with adherence in our 
study. Although, the cost of medication had been reported to be a barrier to adherence 
amongst patients with diabetes mellitus in western Nigeria (Boima et al., 2015), again our 
study did not find this to significantly influence adherence amongst the patients.   
 
This study carried out modeling using OLR to explore explanatory (predictive) factors for 
medication adherence. Individually, age (OR= 1.12), presence of drug side effect (OR= 1.28), 
absence of complication (OR= 1.65) and symptom counts (OR= 0.6) predicted medication 
adherence. When combined in a model, only 3 factors significantly predicted medication 
adherence namely; age (adjusted OR =1.12), absence of complication (adjusted OR=1.57) and 
symptom counts (adjusted OR= 0.65) was found to significantly predict medication 
adherence. The BP control, duration of the disease and gender did not predict medication 
adherence in this study. The implication of these findings is that among patients with 
hypertension and diabetes mellitus attending out-patients clinic in UITH Ilorin, for every year 
increase in age, there are 1.12 times chances of becoming highly adherent from medium 
adherence. Similarly, there are 1.57 times chances that patients that did not report any 
complication will become highly adherent from medium adherence. However, we are mindful 
that our study may not be able to explain the temporality sequence between absence of 
disease complication and medication adherence. But by biological plausibility those patients 
with high adherence are less likely to have medical complications like stroke and congestive 
heart failure. Similarly, we found that with a unit increase in symptom counts, there is 
reduced chance of 0.69 to be highly adherent from medium adherence. Again, there could also 
be some temporality question in this finding. The reduction in symptoms experienced by 
patients could also be as a result of high medication adherence.  
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5.0 Conclusion 
 
The medication adherence among patients with hypertension and diabetes in Ilorin was poor. 
Patients with comorbidity of hypertension and diabetes were more adherent to medication 
than those with hypertension and diabetes alone. Patients with no complications had 1.6 
chances of being adherent to medication. Furthermore the older a patient is, the more 
experienced and adherent he/she is likely to be with drugs while patients suffering from 
disease symptoms are less likely to be adherent with medication. This study recommends 
strategies to reduce multiple drug combinations and promote medication adherence 
counseling and education among patients. 
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